BHC:NYE-Bausch Health Companies Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 7.38

Change

-0.24 (-3.15)%

Market Cap

USD 2.80B

Volume

3.65M

Analyst Target

USD 26.59
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-18 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+3.76 (+2.05%)

USD 83.17B
TAK Takeda Pharmaceutical Co Ltd A..

+0.06 (+0.40%)

USD 47.69B
HLN Haleon plc

+0.13 (+1.28%)

USD 46.39B
RDY Dr. Reddy’s Laboratories Ltd..

+0.63 (+0.78%)

USD 13.90B
CTLT Catalent Inc

+0.02 (+0.03%)

USD 11.03B
ELAN Elanco Animal Health

-0.12 (-0.79%)

USD 7.56B
AMRX Amneal Pharmaceuticals, Inc. C..

N/A

USD 2.63B
PAHC Phibro Animal Health Corporati..

-0.22 (-1.11%)

USD 0.85B
BIOYF Biosyent Inc.

N/A

USD 0.10B
CPHI China Pharma Holdings Inc

+0.01 (+3.07%)

USD 3.47M

ETFs Containing BHC

MJJ 9.90 % 0.00 %

N/A

N/A
MJO 9.90 % 0.00 %

N/A

N/A
DFEN Direxion Daily Aerospace .. 5.65 % 1.09 %

+0.67 (+0%)

USD 0.19B
HHL:CA Harvest Healthcare Leader.. 5.08 % 1.15 %

+0.02 (+0%)

N/A
FMK 4.35 % 0.70 %

N/A

N/A
FIW First Trust Water ETF 3.78 % 0.55 %

-1.22 (0%)

N/A
BUZ 3.50 % 0.75 %

N/A

N/A
SXLI:LSE 2.81 % 0.00 %

N/A

N/A
IISU:LSE 2.65 % 0.00 %

N/A

N/A
VIS Vanguard Industrials Inde.. 2.12 % 0.10 %

-0.21 (0%)

N/A
DUSL Direxion Daily Industrial.. 1.65 % 1.05 %

+0.45 (+0%)

USD 0.03B
UXI ProShares Ultra Industria.. 1.56 % 0.95 %

+0.17 (+0%)

N/A
OEW 1.25 % 0.40 %

N/A

N/A
NHYB:CA NBI High Yield Bond ETF 0.89 % 0.00 %

N/A

CAD 1.07B
JNKS:LSE 0.86 % 0.00 %

N/A

N/A
SYBK:F 0.84 % 0.00 %

N/A

N/A
SYBK:XETRA 0.84 % 0.00 %

N/A

N/A
SJNK:SW 0.84 % 0.00 %

N/A

N/A
SJNK:LSE 0.74 % 0.00 %

N/A

N/A
BND Vanguard Total Bond Marke.. 0.01 % 0.04 %

+0.33 (+0%)

N/A
BSJL 0.00 % 0.41 %

N/A

N/A
CJNK 0.00 % 0.30 %

N/A

N/A
HYG iShares iBoxx $ High Yiel.. 0.00 % 0.49 %

+0.29 (+0%)

N/A
ITA 0.00 % 0.42 %

N/A

N/A
IYJ 0.00 % 0.42 %

N/A

N/A
RFUN 0.00 % 0.51 %

N/A

N/A
SHYL Xtrackers Short Duration .. 0.00 % 0.20 %

+0.13 (+0%)

USD 0.10B
HIG:CA Global Healthcare Income .. 0.00 % 1.02 %

+0.02 (+0%)

CAD 0.05B
HYGV FlexShares® High Yield V.. 0.00 % 0.37 %

+0.09 (+0%)

USD 1.47B
PHYL PGIM Active High Yield Bo.. 0.00 % 0.00 %

+0.15 (+0%)

USD 0.13B
SJB ProShares Short High Yiel.. 0.00 % 0.95 %

-0.07 (0%)

USD 0.09B
VNLA Janus Henderson Short Dur.. 0.00 % 0.35 %

+0.06 (+0%)

USD 2.21B
HYLB Xtrackers USD High Yield .. 0.00 % 0.20 %

+0.15 (+0%)

USD 3.58B
BSJP Invesco BulletShares 2025.. 0.00 % 0.42 %

+0.03 (+0%)

USD 1.01B
WNDU:LSE 0.00 % 0.00 %

N/A

N/A
XDWI:LSE 0.00 % 0.00 %

N/A

N/A
DXS3:F 0.00 % 0.00 %

N/A

N/A
SYBJ:F 0.00 % 0.00 %

N/A

N/A
NUHY Nuveen ESG High Yield Cor.. 0.00 % 0.00 %

+0.10 (+0%)

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.98% 40% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.98% 40% F 15% F
Trailing 12 Months  
Capital Gain -23.04% 20% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.04% 20% F 10% F
Trailing 5 Years  
Capital Gain -68.16% 29% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -68.16% 29% F 5% F
Average Annual (5 Year Horizon)  
Capital Gain -6.58% 38% F 13% F
Dividend Return -6.58% 38% F 10% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 50.84% 38% F 17% F
Risk Adjusted Return -12.94% 44% F 20% F
Market Capitalization 2.80B 38% F 68% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector